Slides
Page 5
DERMA SUCCESS CONTINUES DOUBLE DIGIT GROWTH IN Q3 organic sales growth
Page 6
Q3 2026 organic sales growth DERMA SUCCESS CONTINUES ACROSS REGIONS AMERICAS +8% EUROPE +8% AAA +25%
Page 7
WHITE SPACE EXPANSION AQUAPHOR BODY LAUNCH AQUAPHOR Q3 2026 organic sales growth
Page 8
NEXT LEVEL ACNE INNOVATION LAUNCH OF EUCERIN PROBIOM8
Page 12
organic sales growth, NIVEA incl. Labello
Page 13
H2 YTD 2025 2026
Page 14
FOCUS ON ACCESSIBILITY AND PENETRATION REIGNITE GROWTH THROUGH INNOVATION ACROSS ALL CATEGORIES FULLY LEVERAGE NIVEA’S LOCAL RELEVANCE STEP UP HIGH-IMPACT CONSUMER-FACING INVESTMENTS
Page 19
TESA IMPACTED BY SEMICONDUCTOR SHORTAGE Q3 2026 -2.1% YTD 2026 -4.3%
Page 20
Organic sales growth AUTOMOTIVE OUTPERFORMING MARKET TRENDS ELECTRONICS SEMICONDUCTOR SHORTAGE CONSUMER RECOVERY IN EUROPE Q3 2026 EXCL. ELECTRONICS +1.9% YTD 2026 EXCL. ELECTRONICS +2.4%
Page 21
Q3 2026 9M 2026 (IN € MILLION) 2025 2026 NOMINAL ORGANIC 2025 2026 NOMINAL ORGANIC CONSUMER 1,920 1,940 +1.0% -0.7% 6,251 6,052 -3.2% -2.9% TESA 432 422 -2.0% -4.3% 1,289 1,262 -2.1% -2.1% GROUP 2,352 2,362 +0.4% -1.3% 7,540 7,314 -3.0% -2.8%
Page 23
GUIDANCE 2026 CONSUMER Low-single digit organic net sales decline EBIT margin* of at least 11.0% TESA Net sales flat to slightly growing organically EBIT margin* slightly below previous year GROUP Low-single digit organic net sales decline EBIT margin* of at least 11.8% 2025 data for reference: Consumer EBIT margin* 13.6% tesa EBIT margin* 16.1% Group EBIT margin* 14.0%